• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis.

作者信息

Matushita Cristina S, Coelho Francisco de Assis Romeiro Figueiroa Benicio, Stasiak Camila Edith Stachera, Rodrigues Denise Ferreira, Pianta Diego Bromfman, Kurkowski Flávia Dornelas, Silva Marcelo Moreira da, Souza Sergio Augusto Lopes de, Lopes Rafael Willain, Castro Paulo Henrique Rosado de

机构信息

Sociedade Brasileira de Medicina Nuclear - São Paulo (SP), Brazil.

Pontifícia Universidade Católica do Rio Grande do Sul, Instituto Do Cérebro do Rio Grande do Sul - Porto Alegre (RS), Brazil.

出版信息

Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S116. doi: 10.1590/1806-9282.2023S116. eCollection 2023.

DOI:10.1590/1806-9282.2023S116
PMID:37556635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10411708/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/77061a206234/1806-9282-ramb-69-suppl1-e2023S116-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/8fe94ce485bd/1806-9282-ramb-69-suppl1-e2023S116-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/79a509b6cf11/1806-9282-ramb-69-suppl1-e2023S116-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/77061a206234/1806-9282-ramb-69-suppl1-e2023S116-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/8fe94ce485bd/1806-9282-ramb-69-suppl1-e2023S116-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/79a509b6cf11/1806-9282-ramb-69-suppl1-e2023S116-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/10411708/77061a206234/1806-9282-ramb-69-suppl1-e2023S116-gf03.jpg

相似文献

1
18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis.18F-氟雌二醇正电子发射断层扫描在乳腺癌患者中的应用：一项系统评价和荟萃分析。
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S116. doi: 10.1590/1806-9282.2023S116. eCollection 2023.
2
Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT.超低剂量[18F]-FDG-PET/CT用于妊娠期乳腺癌的分期
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1534-1535. doi: 10.1007/s00259-022-06076-1. Epub 2022 Dec 12.
3
PET Imaging for Breast Cancer.正电子发射断层扫描（PET）成像在乳腺癌中的应用。
Radiol Clin North Am. 2021 Sep;59(5):725-735. doi: 10.1016/j.rcl.2021.05.004.
4
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review.基线 18F-FDG PET-CT 成像对新诊断炎性乳腺癌患者是必要的：叙述性综述。
Chin Clin Oncol. 2021 Dec;10(6):56. doi: 10.21037/cco-21-82. Epub 2021 Nov 16.
5
Metabolic Positron Emission Tomography in Breast Cancer.代谢正电子发射断层扫描在乳腺癌中的应用。
PET Clin. 2023 Oct;18(4):473-485. doi: 10.1016/j.cpet.2023.04.004. Epub 2023 Jun 25.
6
Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour.采用18F-氟脱氧胸苷PET-CT对原发性乳腺癌进行成像，结果显示肿瘤内增殖具有异质性。
Eur J Nucl Med Mol Imaging. 2006 May;33(5):624. doi: 10.1007/s00259-005-0037-7. Epub 2006 Feb 28.
7
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.18F-氟代脱氧葡萄糖正电子发射断层扫描或正电子发射断层扫描/计算机断层扫描在恶性黑素瘤治疗后复发疾病检测中的作用。
Oncology. 2019;97(5):286-293. doi: 10.1159/000501398. Epub 2019 Aug 22.
8
Comparison of F-fluorothymidine Positron Emission Tomography/Computed Tomography and F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer.氟代胸苷正电子发射断层扫描/计算机断层扫描与氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在乳腺癌患者中的比较。
Tomography. 2022 Oct 11;8(5):2533-2546. doi: 10.3390/tomography8050211.
9
Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.F18-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在乳腺癌中的分期/再分期性能：综述和荟萃分析。
Eur J Radiol. 2018 Oct;107:158-165. doi: 10.1016/j.ejrad.2018.09.003. Epub 2018 Sep 5.
10
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描融合成像（18F-FDG PET/CT）摄取水平在原发性乳腺癌中的临床病理及预后相关性
Jpn J Clin Oncol. 2008 Apr;38(4):250-8. doi: 10.1093/jjco/hyn019.

引用本文的文献

1
The Role of [F]FES PET/CT in Breast Cancer Management: An Umbrella Review.[F]FES PET/CT在乳腺癌管理中的作用：一项伞状综述。
Cancers (Basel). 2025 May 13;17(10):1644. doi: 10.3390/cancers17101644.

本文引用的文献

1
Evaluation of tumour heterogeneity by F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment.氟[18F]雌二醇 PET 评估肿瘤异质性作为接受帕博西利联合内分泌治疗的乳腺癌患者的预测指标。
Breast Cancer Res. 2022 Aug 26;24(1):57. doi: 10.1186/s13058-022-01555-7.
2
The clinical value of F-fluoroestradiol in assisting individualized treatment decision in dual primary malignancies.F-氟雌二醇在辅助双原发性恶性肿瘤个体化治疗决策中的临床价值。
Quant Imaging Med Surg. 2021 Sep;11(9):3956-3965. doi: 10.21037/qims-20-1364.
3
Biodistribution of F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader.
新型选择性雌激素受体降解剂林托司特（G1T48）治疗转移性雌激素受体阳性乳腺癌患者时F-FES的生物分布情况
J Nucl Med. 2022 May;63(5):694-699. doi: 10.2967/jnumed.121.262500. Epub 2021 Aug 26.
4
18F-Fluoroestradiol Tumor Uptake Is Influenced by Structural Components in Breast Cancer.18F-氟雌二醇肿瘤摄取受乳腺癌结构成分影响。
Clin Nucl Med. 2021 Nov 1;46(11):884-889. doi: 10.1097/RLU.0000000000003835.
5
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.骨转移的异质性是影响雌激素受体阳性乳腺癌患者预后的一个重要因素。联合应用 [18F] 氟雌二醇 PET/CT 和 [18F] 氟脱氧葡萄糖 PET/CT 的作用。
Eur J Radiol. 2021 Aug;141:109821. doi: 10.1016/j.ejrad.2021.109821. Epub 2021 Jun 10.
6
High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.高剂量他莫昔芬用于高激素受体表达的晚期乳腺癌患者：一项II期试点研究。
Ther Adv Med Oncol. 2021 Feb 26;13:1758835921993436. doi: 10.1177/1758835921993436. eCollection 2021.
7
Evaluation of estrogen expression of breast cancer using F-FES PET CT-A novel technique.使用F-FES PET CT评估乳腺癌雌激素表达——一种新技术。
World J Nucl Med. 2020 Jul 22;19(3):233-239. doi: 10.4103/wjnm.WJNM_71_19. eCollection 2020 Jul-Sep.
8
Comparison of diagnostic sensitivity of [F]fluoroestradiol and [F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer.[F]氟雌二醇与[F]氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对雌激素受体阳性原发性乳腺癌病史患者乳腺癌复发的诊断敏感性比较。
EJNMMI Res. 2020 May 24;10(1):54. doi: 10.1186/s13550-020-00643-z.
9
The Predictive Value of Early Changes in F-Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.氟[18F]雌二醇正电子发射断层扫描/计算机断层扫描在氟维司群 500mg 治疗雌激素受体阳性转移性乳腺癌患者中早期变化的预测价值。
Oncologist. 2020 Nov;25(11):927-936. doi: 10.1634/theoncologist.2019-0561. Epub 2020 Apr 28.
10
F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with F-FDG PET/CT.F-FES PET/CT 对新诊断雌激素受体阳性乳腺癌患者分期和管理的影响：与 F-FDG PET/CT 的回顾性对比研究。
Oncologist. 2019 Dec;24(12):e1277-e1285. doi: 10.1634/theoncologist.2019-0096. Epub 2019 Jul 23.